United States

Enzymatics acquires ArcherDx and Next-Generation Diagnostic Technology

Friday, September 6, 2013 03:14 PM

Enzymatics, a producer of reagents, kits and assays, has acquired Boulder Colo.-based ArcherDx, a developer of NGS-based kits and software solutions for use in investigating cancer treatment. The deal consists of cash, equity and potential milestones worth up to $50 million.

More... »

HeartWare receives FDA approval to enroll supplemental patient cohort

Friday, September 6, 2013 03:12 PM

The FDA has approved an IDE Supplement for HeartWare International, an innovator of less invasive, miniaturized circulatory support technologies for the treatment of advanced heart failure, to commence enrollment in an additional patient cohort for ENDURANCE, the company's Destination Therapy clinical study.

More... »

Michael Seiden named CMO for McKesson Specialty Health, U.S. Oncology Network

Friday, September 6, 2013 03:09 PM

McKesson Specialty Health and The U.S. Oncology Networkhave appointed of Michael V. Seiden, M.D., Ph.D. as chief medical officer.

More... »

Michael J. Fox Foundation hosts first Clinical Trials Fair in Chicago

Friday, September 6, 2013 03:06 PM

The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host its first Clinical Trials Fair in Chicago Sept. 7 to raise awareness and understanding of local Parkinson's research opportunities among patients, their families and friends and other volunteers.

More... »

MPI Research breaks ground on Imaging Center

Friday, September 6, 2013 03:04 PM

MPI Research, in partnership with INVICRO, which has a range of imaging services and software solutions, and 3D Imaging, has broken ground on its new imaging center, set to open next spring at MPI Research’s corporate headquarters in Mattawan, Mich.

More... »

URAC launches two accreditation programs

Friday, September 6, 2013 02:50 PM

Recent healthcare reform efforts are focused on transforming care delivery while also controlling skyrocketing costs. URAC, an independent accreditation organization advancing quality and value throughout healthcare, has launched two new accreditation programs for Clinical Integration and Accountable Care.

More... »

Sensus Healthcare appoints Mark Nestor clinical director

Wednesday, September 4, 2013 04:02 PM

Sensus Healthcare has appointed Dr. Mark Nestor clinical director. Nestor joins a panel of medical advisory board members. He will lead the company's efforts in training, education and clinical research as the company continues to expand its SRT technology for non-invasive skin cancer treatment for NMSC as well as treatment for Keloid scars.

More... »

Karen M. Emmons named VP, director of Kaiser Foundation Research Institute

Wednesday, September 4, 2013 04:00 PM

Kaiser Permanente, a health research organization, has named Karen M. Emmons, Ph.D., associate dean for research at the Harvard School of Public Health, vice president for research and director of the Kaiser Foundation Research Institute, effective Sept. 30.

More... »

Enanta receives additional $9.2m funding from NIAID

Wednesday, September 4, 2013 03:54 PM

The National Institute of Allergy and Infectious Diseases (NIAID), a division of the NIH, has agreed to provide additional funding of $9.2 million to its existing contract with Enanta Pharmaceuticals, an R&D-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, to fund preclinical and early clinical development for a new class of bridged bicyclic antibiotics known as Bicyclolides.

More... »

Covance, Indiana CTSI collaborate

Wednesday, September 4, 2013 12:28 PM

CRO Covance and the Indiana Clinical and Translational Sciences Institute (CTSI), part of the Indiana University (IU) School of Medicine, will collaborate to conduct early clinical trials for new medicines. 

More... »